These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 12645834

  • 1. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
    Ringbaek T, Viskum K.
    Respir Med; 2003 Mar; 97(3):264-72. PubMed ID: 12645834
    [Abstract] [Full Text] [Related]

  • 2. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease.
    Sin DD, Tu JV.
    Thorax; 2000 Mar; 55(3):194-7. PubMed ID: 10679537
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D, Vitale A, Lahiri B, ZuWallack R.
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.
    Ann Intern Med; 2008 Sep 16; 149(6):380-90. PubMed ID: 18794557
    [Abstract] [Full Text] [Related]

  • 6. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.
    Oostenbrink JB, Rutten-van Mölken MP, Al MJ, Van Noord JA, Vincken W.
    Eur Respir J; 2004 Feb 16; 23(2):241-9. PubMed ID: 14979498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R, Joos GF, Fogarty C, Faiferman I, Hirschberg S, Vessey R, Wouters EF.
    Pulm Pharmacol Ther; 2008 Feb 16; 21(2):385-92. PubMed ID: 18023600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D, Zhu CQ, Sharma S, Church A, Kalberg CJ.
    Pulm Pharmacol Ther; 2015 Apr 16; 31():85-91. PubMed ID: 25197005
    [Abstract] [Full Text] [Related]

  • 16. Ipratropium for acute asthma in adults.
    Holten KB.
    Can Fam Physician; 2000 Dec 16; 46():2406-7. PubMed ID: 11153407
    [No Abstract] [Full Text] [Related]

  • 17. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
    Campbell S.
    Arch Intern Med; 1999 Jan 25; 159(2):156-60. PubMed ID: 9927098
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.